Showing results (11-20 of 80) with videos related to
Sort By:
Pageof 8
Clinical Endocrinology|July 1, 1987
Effect of thyroxine replacement therapy on plasma insulin-like growth factor 1 levels and growth hormone responses to growth hormone releasing factor in hypothyroid patientsR Valcavi, C Dieguez, M Preece, et al.The Journal of Endocrinology|October 1, 1987
Alpha-adrenoreceptor blockade with thymoxamine reduces basal thyrotrophin levels but does not influence circadian thyrotrophin changes in manR Valcavi, C Dieguez, C Azzarito, et al.The Journal of Clinical Endocrinology and Metabolism|September 1, 1993
Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginineR Valcavi, F Valente, C Dieguez, et al.The Journal of Clinical Endocrinology and Metabolism|November 1, 1994
Reversible effects of cessation and recommencement of thyroxine treatment on insulin-like growth factors (IGFs) and IGF-binding proteins in patients with total thyroidectomyJ P Miell, M Zini, J D Quin, et al.The Journal of Clinical Endocrinology and Metabolism|October 1, 1994
Effects of oral glucose administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH release in children and adultsR Valcavi, M Zini, C Volta, et al.Clinical Endocrinology|August 1, 1991
Effect of pyridostigmine and pirenzepine on GH responses to GHRH in hyperthyroid patientsR Valcavi, C Dieguez, M Zini, et al.Clinical Endocrinology|September 1, 1988
Alpha-2-adrenergic pathways release growth hormone via a non-GRF-dependent mechanism in normal human subjectsR Valcavi, C Dieguez, M D Page, et al.The Journal of Clinical Endocrinology and Metabolism|July 1, 1992
Sinus node function in hyperthyroid patientsR Valcavi, C Menozzi, E Roti, et al.Clinical Endocrinology|April 1, 1987
Effect of oral administration of melatonin on GH responses to GRF 1-44 in normal subjectsR Valcavi, C Dieguez, C Azzarito, et al.Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|June 8, 2000
[The limits of controlled clinical studies: the case of rheumatology]I PortioliPageof 8